Ischemia, Myocardial
9
2
2
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
11.1%
1 terminated out of 9 trials
66.7%
-19.8% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (9)
Imaging and Treatment Planning for Cardiac Radioablation
INOCA-NA a Local Prospective Registry
Comparison of an Ultra-low Strut Thickness Everolimus-eluting Biodegradable Polymer Stent Versus Durable Polymer Everolimus-eluting Stents in Patients Treated with Percutaneous Coronary Intervention
Remote Ischemic Preconditioning in ACS Patients
Coronary Flow Reserve (CFR) in Cardiovascular Risk Stratification
Quantitative Stress Echocardiography to Diagnose Myocardial Ischaemia
Risk Profiling for Patients With Isolated or Combined Coronary and Cerebral Ischemia, and Current Management Status
Extracellular Matrix Marker of Arrhythmia Risk (EMMA)
The Ischemia Modified Albumin In Diagnosing Ischemic New Events